ESBB COVID-19 Survey - To be completed by May 4th

Dear members, partners and friends of ESBB,

We highly appreciate you taking the time to answer this survey which will take about 10 minutes for 48 questions. This survey should help us all to understand and learn about shortcomings, needs and strategies for the biobank community in such an unprecedented challenging and difficult time due to the COVID-19 pandemic. Biobanks can play a significant role in providing samples and data for COVID-19 associated research in order to overcome this devastating pandemic. Thus, guaranteeing our biobanks’ functionality during this and potentially future crises is fundamental.

This survey is fully anonymous. However, in case you are interested in getting engaged in our ESBB COVID-19 Task Force, please e-mail our ESBB office at ESBB@mci-group.com. The results of this survey will be shown on our website (www.esbb.org) and may lead to a scientific publication or white paper. Your feedback to the survey and specifically your free text reply at the end of the survey may direct us to develop tools and support or bring clarity to meet your particular COVID-19 needs.
Please make sure to answer this Survey by April 30th!

1.Are you a (please tick all that apply)
2.If you are a clinician, nurse or technician, are you working in
3.In this survey, are you representing a/an (please tick all that apply)
4.If you are working in a biobank, how is your biobank best described? (please tick all that apply)
5.How long have you been working in the respective biobank or other field?
6.In which geographical region according to the United Nations is your institution located?
7.What is your highest degree:
8.How old are you?
9.Are you a member of
10.Now we’d like to hear about your experiences during the COVID-19 crisis.

Was your working place operational all the time since COVID-19 crisis started?
11.In case your working place was shut down due to the COVID-19 crisis, for how long?
12.Was your work affected by other restrictions than shut down?
13.Now we’d like to hear about COVID-19 effects on biobanking.

Is your biobank by law/regulations allowed to collect/store COVID-19 samples?
14.Does your biobank collect COVID-19 samples?
15.If your biobank is involved in COVID-19 collections, to what extend (please tick all that apply)
16.Why do you think your biobank is involved in COVID-19 sampling? (please tick all that apply)
17.What are the difficulties you encountered? (please tick all that apply)
18.Does your biobank actually collect COVID samples (please tick all that apply)
19.Does your biobank plan to collect COVID samples (please tick all that apply)
20.How is your interaction with the local ethics committee to act on COVID-19 ethics approvals and/or guidance best described:
21.How fast did your local ethics board react to requests/ethical applications?
22.Does your biobank collect (please tick all that apply)
Yes
Plan to do so
No
a) Neonate COVID-19 positive samples
b) Paediatric COVID-19 positive samples
c) COVID-19 positive samples from oncology patients
d) COVID-19 positive samples from cardiology patients
e) COVID-19 positive samples from diabetic patients
f) COVID-19 positive samples from immune disease patients
23.If you actually collect COVID-19 samples, what type? (please complete all that apply)
24.If you plan to collect COVID-19 samples, what type? (please complete all that apply)
25.Do you perform longitudinal sampling for COVID-19 patients?
26.If yes, how often do you sample subsequently from the same patient?
27.Is your sampling strategy for COVID-19 harmonized with other biobanks?
28.Would your COVID-19 samples be available for external research projects?
29.If yes, would your COVID-19 samples also be available for industry projects?
30.Are you collecting clinical data parameters with the samples?
31.Do you submit COVID-19 data to national registries?
32.Do you submit COVID-19 data to international registries?
33.Do you submit COVID-19 data to the LEOSS (Lean European Open Survey on SARS-CoV-2 Infected Patients) register?
34.Do you receive any additional funding specific for COVID-19 biobanking? (please tick all that apply)
35.We are further interested to understand more about the security measures you take for sampling, processing, and storage.

Do you need a certain safety level to store your samples due to regulations?
36.Do you need a certain safety level for sample processing (e.g., extract PBMCs or DNA from sputum) due to regulations?
37.Does your biobank need to collaborate with other institutes for sample processing due to regulations, e.g., as your facility does not have the required safety level?
38.At what temperatures do you store your samples? (please tick all that apply)
39.Now we want to hear about your supplies during the COVID-19 crisis.

Did you, and do you still, have sufficient self-protection available?
Yes
No
a) Surgical mask?
b) FFP2 mask?
c) FFP3 mask?
d) Protective gear?
e) Gloves?
f) Disinfectant?
40.Did you experience any shortcomings for self-protection gear?
41.Did you experience any shortcomings on consumables, e.g., tubes, kits, reagents for sample processing/storage?
42.Now we’d like to understand what you would expect from our ESBB COVID Task Force.

Would you like to be part of our ESBB COVID-19 Task Force:
43.What would you expect from our ESBB COVID-19 Task Force: (please tick all that apply)
44.How often would you like to have a COVID-19 Webinar?
45.What would be your preferred day of the week for such a webinar? (please tick all that apply)
46.What would be your preferred time of the day for such a webinar? (please tick all that apply)
47.How long should such a webinar ideally last:
48.Please use the space below to suggest or comment on anything we might have missed to ask and/or what you deem being crucial to support the biobank community, clinicians, nurses, and patients overall.
Current Progress,
0 of 48 answered